Esomeprazole: Dosage, Side Effects, Brands & Clinical Use | MedexInfo
Labels:
Proton Pump Inhibitor (PPI)
Esomeprazole (Esomeprazole magnesium)
Rx Only
Generic NameEsomeprazole magnesium
Therapeutic ClassProton Pump Inhibitor (PPI)
Common Dose20–40 mg/day
Max / 24h40 mg (Adults)
PregnancyCategory B
Indications ▼
Gastroesophageal reflux disease (GERD)
Peptic ulcer disease
H. pylori eradication (with antibiotics)
Zollinger-Ellison syndrome
NSAID-induced ulcer prevention
Mechanism & Pharmacokinetics ▼
Mechanism: Inhibits H+/K+ ATPase in gastric parietal cells, reducing acid secretion.
Pharmacokinetics: Rapid oral absorption; Tmax ~1–2 hrs. Bioavailability 64%. Metabolized in liver (CYP2C19, CYP3A4). Half-life ~1–1.5 hrs. Excreted mainly via urine.
Dosage & Administration ▼
| Patient Category | Recommended Dose | Max / 24h |
|---|---|---|
| Adults (GERD) | 20–40 mg once daily | 40 mg |
| H. pylori eradication | 20 mg twice daily with antibiotics | 40 mg |
| Children ≥1 yr | 10–20 mg once daily | 20 mg |
Side Effects ▼
Common: Headache, nausea, diarrhea, abdominal pain
Rare: Dizziness, rash, vitamin B12 deficiency (long-term)
Serious: Hypomagnesemia, acute interstitial nephritis
Contraindications ▼
Hypersensitivity to esomeprazole or other PPIs
Severe hepatic impairment
Drug Interactions ▼
Clopidogrel: reduced activation
Warfarin: may increase INR
Ketoconazole/Itraconazole: reduced absorption
Pregnancy & Lactation ▼
Generally considered safe (Category B)
Use with caution during breastfeeding
Clinical / Research Summary ▼
Clinical Efficacy: Esomeprazole, the S-isomer of omeprazole, provides more consistent and prolonged gastric acid suppression, resulting in higher intragastric pH control compared to racemic PPIs.
GERD Healing Outcomes: Large multicenter trials demonstrate superior healing rates of erosive esophagitis and faster symptom resolution in moderate to severe GERD patients.
H. pylori Eradication Support: Esomeprazole enhances antibiotic stability and activity by maintaining elevated gastric pH, improving eradication success when used in combination regimens.
NSAID-Associated Ulcer Prevention: Clinical studies confirm its effectiveness in preventing gastric and duodenal ulcers in patients on long-term NSAID therapy.
Pharmacokinetic Advantage: Reduced first-pass metabolism leads to higher bioavailability and less inter-patient variability, especially in CYP2C19 extensive metabolizers.
Long-Term Use Evidence: Long-term observational data support overall safety, though chronic therapy may be associated with hypomagnesemia, vitamin B12 deficiency, and increased infection risk.
Current Research Trends: Recent research focuses on step-down therapy, on-demand use in mild GERD, and comparison with potassium-competitive acid blockers (P-CABs).
Storage & Handling ▼
Store at 15–30°C, protect from moisture and light
Keep out of reach of children
Patient Counseling Points ▼
Take 30–60 minutes before meals
Do not crush or chew capsules
Report persistent diarrhea or abdominal pain
Brand Names (Bangladesh & Global) ▼
Bangladesh (Local Brands, 20):
Global / International Brands (20):
Nexium
Esomepraz
Esopraz
Esomag
Esobex
Esomol
Esopral
Esomep
Nexium-M
Esomep-SR
Nexium
Esomeprazole Teva
Esomeprazole Sandoz
Esomeprazole Dr. Reddy's
Esomeprazole Ranbaxy
Medical Disclaimer: This clinical summary is for informational purposes only. Always follow guidance from a qualified healthcare professional for dosage, interactions, and use.
.png)
